Essential Thrombocythaemia (ET)
Thrombo means clotting and cythaemia relates to blood cells. It is also known as primary thrombocythaemia or essential thrombocytosis.
Essential thrombocythaemia (ET) is a type of blood disorder called a myeloproliferative neoplasm. These are conditions that cause an increase in the number of blood cells.
The World Health Organisation (WHO) classes all myeloproliferative neoplasms as blood cancers. This is because the bone marrow is producing blood cells in an uncontrolled way. But many people with myeloproliferative neoplasms feel well and only need gentle treatment. The disorders often develop slowly and progress slowly. Or they can remain stable for a while.
Find out more about myeloproliferative neoplasms
ET usually develops very slowly. It can affect people of any age. But it usually affects middle aged and older people. The average age at diagnosis is about 65 years although it can affect children and young adults.
The bone marrow is the soft inner part of our bones that makes blood cells. All blood cells start from the same type of cell called a stem cell. The stem cell makes immature blood cells. The immature cells go through various stages of development before they become fully developed blood cells and are released into the blood. As well as platelets, the bone marrow makes:
red blood cells to carry oxygen around our bodies
white blood cells to fight infection
This diagram shows how different types of cells develop from a single blood stem cell:
In essential thrombocythaemia, the stem cells make too many platelets. The extra platelets might form blood clots. The platelets can also collect in the spleen, which makes it bigger.
Treatment controls ET for most people for many years. But for some, ET can lead to other problems, such as scarring of their bone marrow. This is called myelofibrosis. The risk of this happening increases over time.
Find out more about myelofibrosis
More rarely ET can develop into acute myeloid leukaemia (AML). Fewer than 5 in 100 people (5%) with ET develop AML.
We don’t know exactly what causes ET. Researchers have found that around 50 to 60 in 100 people (around 50 to 60%) with ET have a change in the JAK2 gene. The JAK2 gene makes a protein that controls how many blood cells are made by the stem cells. This gene change causes too much of this protein to be made and that causes the stem cells to make more platelets. People with ET might also have a genetic change in either the CALR or MPL gene.
Genetic faults might happen because you’ve been exposed to hazardous chemicals over time but more research is needed. Often gene changes are because of a copying mistake when a cell is dividing. In most cases, these genetic faults happen during a person’s lifetime. You are not born with them, so you can’t pass them on to your children.
In rarer cases, you might have a history of myeloproliferative neoplasms (MPNs) in your family. This might mean there is a faulty gene in your family that increases your risk of developing MPNs.
Many people find out they have ET when they are having a blood test for something else. This is because ET usually develops slowly and doesn’t cause symptoms at first. As it progresses it causes symptoms.
Most of the symptoms happen as a result of blood clots forming or because of bleeding problems. Bleeding problems are less common than clots. They can develop because the platelets are not fully mature and don’t work normally.
Symptoms include:
tiredness (fatigue)
headaches
dizziness, feeling lightheaded and blurred vision
burning and tingling in hands and feet - this often feels worse with heat and better with cold
pain or discomfort in the tummy (abdomen) from an enlarged spleen
bruising more easily
purplish mottled skin changes, usually on the legs
nosebleeds or bleeding gums
black or tarry poo, if there is any bleeding in the bowel
vaginal bleeding when you are not due to have a period or abnormally heavy periods
The symptoms of a blood clot depend on where it is in the body. They can form anywhere but most commonly develop in the deep veins in the:
leg
lung
brain
heart
Not everyone with ET will have these problems. People who have diabetes or heart disease are at higher risk. You may have other health conditions that increase your risk of blood clots. Your specialist will discuss these with you.
Essential thrombocythameia is rare, so if you have any of these symptoms it is more likely to be something else. But it is still important to contact your doctor to find out what is causing them.
The first test to diagnose essential thrombocythaemia is a blood test.
Find out more about tests and treatment for essential thrombocythaemia
Last reviewed: 13 Nov 2023
Next review due: 13 Nov 2026
Find out about other conditions that can be confused with cancer or can develop into a cancer. We also have information about less common blood cancers here.
Myeloproliferative neoplasms are a group of rare disorders of the bone marrow that cause an increase in the number of blood cells.
The first test to diagnose essential thrombocythaemia is usually a blood test. This is to check the number of platelets in your blood. In ET there is an abnormally high level of platelets.
Researchers around the world are looking at better ways to treat essential thrombocythaemia and manage treatment side effects.
Myelofibrosis is a rare blood cancer. It causes scarring of the bone marrow which can develop into acute leukaemia in some people.
AML starts from young white blood cells called granulocytes or monocytes in the bone marrow. Find out about symptoms, how it is diagnosed and treated, and how to cope.
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
